Stay updated on Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Sign up to get notified when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.

Latest updates to the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.5.4, replacing the previous revision tag. This indicates a minor update to the page version.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedClinicalTrials.gov updated the displayed site revision from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedAdded a Hepatocellular carcinoma topic tag and a new link to the Genetic and Rare Diseases Information Center in the Resources section. Updated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check65 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2. This is a minor metadata/UI update with no impact on study information.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision: v3.4.2 has been added, while the previous funding-status notice (Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.